| GO:0035789 | metanephric mesenchymal cell migration | 1 | 1 | 
| GO:0005515 | protein binding | 184 | 6024 | 
| GO:0034405 | response to fluid shear stress | 1 | 8 | 
| GO:0005737 | cytoplasm | 110 | 3767 | 
| GO:0008543 | fibroblast growth factor receptor signaling pathway | 9 | 156 | 
| GO:0004713 | protein tyrosine kinase activity | 5 | 82 | 
| GO:0046777 | protein autophosphorylation | 7 | 158 | 
| GO:0032956 | regulation of actin cytoskeleton organization | 1 | 30 | 
| GO:0010863 | positive regulation of phospholipase C activity | 1 | 8 | 
| GO:0005161 | platelet-derived growth factor receptor binding | 1 | 14 | 
| GO:0090280 | positive regulation of calcium ion import | 1 | 13 | 
| GO:0043066 | negative regulation of apoptotic process | 31 | 424 | 
| GO:0043202 | lysosomal lumen | 1 | 63 | 
| GO:2000379 | positive regulation of reactive oxygen species metabolic process | 2 | 23 | 
| GO:0043548 | phosphatidylinositol 3-kinase binding | 2 | 21 | 
| GO:0036120 | cellular response to platelet-derived growth factor stimulus | 1 | 5 | 
| GO:0007165 | signal transduction | 24 | 907 | 
| GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 2 | 106 | 
| GO:0030335 | positive regulation of cell migration | 7 | 127 | 
| GO:0014911 | positive regulation of smooth muscle cell migration | 1 | 16 | 
| GO:0038095 | Fc-epsilon receptor signaling pathway | 12 | 168 | 
| GO:0009986 | cell surface | 11 | 402 | 
| GO:0016477 | cell migration | 5 | 128 | 
| GO:0005886 | plasma membrane | 45 | 2582 | 
| GO:0060981 | cell migration involved in coronary angiogenesis | 1 | 1 | 
| GO:0061298 | retina vasculature development in camera-type eye | 1 | 7 | 
| GO:0005017 | platelet-derived growth factor-activated receptor activity | 1 | 1 | 
| GO:0046488 | phosphatidylinositol metabolic process | 1 | 10 | 
| GO:0048745 | smooth muscle tissue development | 1 | 11 | 
| GO:0043406 | positive regulation of MAP kinase activity | 4 | 46 | 
| GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling | 1 | 51 | 
| GO:0048661 | positive regulation of smooth muscle cell proliferation | 4 | 49 | 
| GO:0007173 | epidermal growth factor receptor signaling pathway | 12 | 189 | 
| GO:0045840 | positive regulation of mitosis | 2 | 28 | 
| GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway | 1 | 2 | 
| GO:0016021 | integral component of membrane | 27 | 1982 | 
| GO:0072262 | metanephric glomerular mesangial cell proliferation involved in metanephros development | 1 | 2 | 
| GO:0005524 | ATP binding | 60 | 1298 | 
| GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | 1 | 3 | 
| GO:0005925 | focal adhesion | 19 | 366 | 
| GO:0001894 | tissue homeostasis | 1 | 17 | 
| GO:0072277 | metanephric glomerular capillary formation | 1 | 3 | 
| GO:0016020 | membrane | 90 | 1681 | 
| GO:0035909 | aorta morphogenesis | 1 | 12 | 
| GO:0048011 | neurotrophin TRK receptor signaling pathway | 15 | 269 | 
| GO:0016023 | cytoplasmic membrane-bounded vesicle | 5 | 105 | 
| GO:0048407 | platelet-derived growth factor binding | 1 | 11 | 
| GO:0032967 | positive regulation of collagen biosynthetic process | 1 | 21 | 
| GO:0048705 | skeletal system morphogenesis | 1 | 24 | 
| GO:0035441 | cell migration involved in vasculogenesis | 1 | 2 | 
| GO:0019901 | protein kinase binding | 21 | 317 | 
| GO:0060326 | cell chemotaxis | 2 | 50 | 
| GO:2000573 | positive regulation of DNA biosynthetic process | 1 | 11 | 
| GO:0050921 | positive regulation of chemotaxis | 2 | 13 | 
| GO:0072075 | metanephric mesenchyme development | 1 | 8 | 
| GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 2 | 26 | 
| GO:0030325 | adrenal gland development | 1 | 21 | 
| GO:0038091 | positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway | 1 | 3 | 
| GO:0048008 | platelet-derived growth factor receptor signaling pathway | 2 | 27 | 
| GO:0005019 | platelet-derived growth factor beta-receptor activity | 1 | 1 | 
| GO:0072278 | metanephric comma-shaped body morphogenesis | 1 | 3 | 
| GO:0007186 | G-protein coupled receptor signaling pathway | 7 | 289 | 
| GO:0048015 | phosphatidylinositol-mediated signaling | 7 | 114 | 
| GO:0042060 | wound healing | 2 | 64 | 
| GO:0045087 | innate immune response | 24 | 596 | 
| GO:0031226 | intrinsic component of plasma membrane | 1 | 13 | 
| GO:0038085 | vascular endothelial growth factor binding | 1 | 4 | 
| GO:0055093 | response to hyperoxia | 1 | 13 | 
| GO:0072284 | metanephric S-shaped body morphogenesis | 1 | 5 | 
| GO:0004992 | platelet activating factor receptor activity | 2 | 2 | 
| GO:0016324 | apical plasma membrane | 5 | 199 | 
| GO:0032516 | positive regulation of phosphoprotein phosphatase activity | 1 | 10 | 
| GO:0071670 | smooth muscle cell chemotaxis | 1 | 2 | 
| GO:0048839 | inner ear development | 2 | 37 | 
| GO:0070062 | extracellular vesicular exosome | 104 | 2400 | 
| GO:0005634 | nucleus | 136 | 4559 | 
| GO:0018108 | peptidyl-tyrosine phosphorylation | 7 | 132 | 
| GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 1 | 12 | 
| GO:0032526 | response to retinoic acid | 2 | 46 | 
| GO:0009636 | response to toxic substance | 3 | 65 | 
| GO:0008284 | positive regulation of cell proliferation | 8 | 382 | 
| GO:0001701 | in utero embryonic development | 8 | 201 | 
| GO:0006024 | glycosaminoglycan biosynthetic process | 1 | 23 | 
| GO:0055003 | cardiac myofibril assembly | 1 | 11 | 
| GO:0005102 | receptor binding | 6 | 260 | 
| GO:0032355 | response to estradiol | 5 | 71 | 
| GO:0042542 | response to hydrogen peroxide | 1 | 39 |